Skip to content
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Issuance page – Rights issue 2025
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Issuance page – Rights issue 2025
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
EN
SV
Press releases
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2025
2024
2023
2022
2023
2023-11-24 08:00
Prolight Diagnostics achieves ISO 13485 accreditation
Regulatory
2023-11-23 08:00
Prolight Diagnostics shows proof of performance in whole blood
Regulatory
2023-11-13 12:00
TTP evolves MicroFlex technology
2023-10-26 08:45
Notice of extraordinary general meeting in Prolight Diagnostics AB (publ)
Regulatory
2023-10-26 08:30
The Board of Directors of Prolight Diagnostics AB (publ) resolves on a rights issue of units of approximately SEK 98.8 million and proposes a directed issue of shares of approximately SEK 20.9 million
Regulatory
MAR
2023-10-09 08:00
Prolight Diagnostics forms Clinical Advisory Board
2023-10-02 08:00
Prolight Diagnostics publishes investor letter for October 2023
Regulatory
2023-09-06 08:00
Merger Market publishes interview with Prolight Diagnostics CEO, Ulf Bladin
2023-08-29 08:00
Prolight Diagnostics publishes half-year report, 2023
Regulatory
MAR
2023-07-28 08:00
Prolight Diagnostics publishes investor letter for July 2023
Regulatory
Previous
Next